The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Casacalenda, N.
* Articles by Looper, K.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Casacalenda, N.
* Articles by Looper, K.
Related Collections
* Depression
* Behavior Therapy
* Cognitive Therapy
* Other Psychotherapy
* Antidepressants
Am J Psychiatry 159:1354-1360, August 2002
© 2002 American Psychiatric Association


Article

Remission in Major Depressive Disorder: A Comparison of Pharmacotherapy, Psychotherapy, and Control Conditions

Nicola Casacalenda, M.D., J. Christopher Perry, M.P.H., M.D., and Karl Looper, M.D.

OBJECTIVE: The aim of this study was to assess the percentages of full remission in studies of patients with major depressive disorder in which pharmacotherapy, psychotherapy, and control conditions were directly compared. METHOD: Computerized searches of the MEDLINE and PsychINFO databases up to November 2000 were used to identify six multiple-cell randomized, controlled, double-blind trials for well-defined major depressive disorder in which medications, psychotherapy, and control conditions were directly compared and for which remission percentages were reported. RESULTS: The studies included a total of 883 outpatients with mild to moderate, primarily nonmelancholic, nonpsychotic major depressive disorder. Treatment duration ranged from 10 to 34 weeks (median=16 weeks). An intent-to-treat analysis indicated that, according to measurements by independent blind raters, antidepressant medication (tricyclic antidepressants and phenelzine) and psychotherapy (primarily cognitive behavior and interpersonal therapies) were more efficacious than control conditions, but there were no differences between active treatments. The percentages of remission for all patients randomly assigned to medication, psychotherapy, and control conditions were 46.4%, 46.3%, and 24.4%, respectively. Furthermore, significantly more patients dropped out of control conditions (54.4%) than either treatment with medication (37.1%) or psychotherapy (22.2%). CONCLUSIONS: Both antidepressant medication and psychotherapy may be considered first-line treatments for mildly to moderately depressed outpatients.




This article has been cited by other articles:


Home page
Clin TrialsHome page
E. Frank, G. B Cassano, P. Rucci, A. Fagiolini, L. Maggi, H. C Kraemer, D. J Kupfer, B. Pollock, R. Bies, V. Nimgaonkar, et al.
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression
Clinical Trials, June 1, 2008; 5(3): 253 - 261.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol, June 1, 2008; 22(4): 343 - 396.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
D. Nutt, K. Demyttenaere, Z. Janka, T. Aarre, M. Bourin, P. L. Canonico, J. L. Carrasco, and S. Stahl
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure
J Psychopharmacol, July 1, 2007; 21(5): 461 - 471.
[Abstract] [PDF]


Home page
Clin TrialsHome page
M. H Trivedi, T. L Greer, B. D Grannemann, T. S Church, D. I Galper, P. Sunderajan, S. R Wisniewski, H. O Chambliss, A. N Jordan, C. Finley, et al.
TREAD: TReatment with Exercise Augmentation for Depression: study rationale and design
Clinical Trials, June 1, 2006; 3(3): 291 - 305.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
D. C. Mohr, S. L. Hart, L. Julian, C. Catledge, L. Honos-Webb, L. Vella, and E. T. Tasch
Telephone-Administered Psychotherapy for Depression
Arch Gen Psychiatry, September 1, 2005; 62(9): 1007 - 1014.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
J. Gonzalez, J. W. Williams Jr., P. H. Noel, and S. Lee
Adherence to Mental Health Treatment in a Primary Care Clinic
J Am Board Fam Med, March 1, 2005; 18(2): 87 - 96.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
A. RIFKIN
Comparing Depression Treatments
Am J Psychiatry, June 1, 2003; 160(6): 1186 - 1187.
[Full Text]


Home page
Evid. Based Ment. HealthHome page
R. W Lam
Review: antidepressants and psychotherapy may be equally effective for promoting remission in major depressive disorder
Evid. Based Ment. Health, May 1, 2003; 6(2): 45 - 45.
[Full Text] [PDF]


Home page
JCOHome page
J. J. Sigal, J. C. Perry, J. M. Robbins, M.-A. Gagne, and E. Nassif
Maternal Preoccupation and Parenting as Predictors of Emotional and Behavioral Problems in Children of Women With Breast Cancer
J. Clin. Oncol., March 15, 2003; 21(6): 1155 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs., January 1, 2003; 6(1): e1 - 1.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org